Category News

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

 a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology…

Read MoreDeliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

London North West University Healthcare NHS Trust Finds Digital Way Forward with PhenoTips’ Genomic Health Record

-London North West University Healthcare NHS Trust (LNWH) unites multiple geographically distinct hospitals with PhenoTips’ cloud-hosted Genomic Health Record (GHR) to digitize genomics and deliver on “Our Way Forward” 5-year…

Read MoreLondon North West University Healthcare NHS Trust Finds Digital Way Forward with PhenoTips’ Genomic Health Record

Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

(Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, has officially broken ground on its new state-of-the-art manufacturing facility, located in Athenry, Co. Galway.…

Read MoreDexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Hackensack Meridian Health (“HMH”), a leading not-for-profit health care organization and…

Read MoreCompass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

Elevance Health Addresses Healthcare’s Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Elevance Health gives eligible consumers no-cost access to customized suite of digital and virtual health tools through funding from the Affordable Connectivity Program Elevance Health announced at the Consumer Electronics…

Read MoreElevance Health Addresses Healthcare’s Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Henry Schein Medical Introduces the Henry Schein ‘RISE’ Platform for Ambulatory Surgery Centers

 Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), today announced the launch of Henry Schein RISE (Resources, Infection Prevention, Solutions & Support, Education) – a platform designed to provide ambulatory surgery…

Read MoreHenry Schein Medical Introduces the Henry Schein ‘RISE’ Platform for Ambulatory Surgery Centers

Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the Delaware Court of Chancery (the “Court”) ruled that the nomination notice (the “Notice”) submitted by a member…

Read MoreDelaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid